Literature DB >> 6789360

The stimulus properties of gamma-hydroxybutyrate.

J C Winter.   

Abstract

Fourteen rats were trained to discriminate the effects of gamma-hydroxybutyrate (GHB) (sodium salt, 200 mg/kg) and saline in a two-lever choice task using a fixed ratio 10 schedule of water reinforcement. Intermediate responding, i.e., responding not fully appropriate for either training condition was observed in tests following morphine, lysergic acid diethylamide, chlordiazepoxide, and the presumed GABA-mimetics muscimol, gamma-butyrolactone, baclofen, and 3-aminopropane sulfonic acid. Naloxone blocked the intermediate results following morphine, but had no effect on GBH-induced stimulus control. The GABA antagonist bicuculline partially blocked GHB, but pizotyline, phentolamine, and butaclamol were without effect. It is concluded that the compound stimulus produced by GHB is most closely associated with GABAergic systems, but that minor opiate and serotonergic components are present as well.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6789360     DOI: 10.1007/BF00426468

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Differences in the stimulus properties of barbital and hallucinogens.

Authors:  I D Hirschhorn; J C Winter
Journal:  Pharmacol Biochem Behav       Date:  1975 May-Jun       Impact factor: 3.533

2.  [Comparative pharmacology of butyric acid salts and of 4-hydroxybutyric acid].

Authors:  J M JOUANY; J GERARD; B BROUSSOLLE; M REYNIER; A ORSETTI; C VERMUTH; C BARON
Journal:  Agressologie       Date:  1960-10

3.  Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra.

Authors:  N E Andén; G Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli.

Authors:  I D Hirschhorn; J C Winter
Journal:  Psychopharmacologia       Date:  1971

5.  Conversion in vivo of gamma-aminobutyric to gamma-hydroxybutyric acid in the rat.

Authors:  R H Roth; N J Giarman
Journal:  Biochem Pharmacol       Date:  1969-01       Impact factor: 5.858

6.  Neurochemical basis of the therapeutic effect of gamma-aminobutyric acid and its derivatives.

Authors:  I A Sytinsky; A T Soldatenkov; A Lajtha
Journal:  Prog Neurobiol       Date:  1978       Impact factor: 11.685

7.  Gamma hydroxybutyrate in the monkey. I. Electroencephalographic, behavioral, and pharmacokinetic studies.

Authors:  O C Snead
Journal:  Neurology       Date:  1978-07       Impact factor: 9.910

8.  Identification of endogenous gamma-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain.

Authors:  J D Doherty; S E Hattox; O C Snead; R H Roth
Journal:  J Pharmacol Exp Ther       Date:  1978-10       Impact factor: 4.030

9.  gamma-Hydroxybutyric acid is not a GABA-mimetic agent in the spinal cord.

Authors:  I Osorio; R A Davidoff
Journal:  Ann Neurol       Date:  1979-08       Impact factor: 10.422

Review 10.  Receptors for the age of anxiety: pharmacology of the benzodiazepines.

Authors:  J F Tallman; S M Paul; P Skolnick; D W Gallager
Journal:  Science       Date:  1980-01-18       Impact factor: 47.728

View more
  16 in total

1.  Behavioral effects of gamma-hydroxybutyrate, its precursor gamma-butyrolactone, and GABA(B) receptor agonists: time course and differential antagonism by the GABA(B) receptor antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP35348).

Authors:  Wouter Koek; Susan L Mercer; Andrew Coop; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2009-06-29       Impact factor: 4.030

2.  Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons.

Authors:  Amy K Goodwin; Roland R Griffiths; P Rand Brown; Wolfgang Froestl; Cornelis Jakobs; K Michael Gibson; Elise M Weerts
Journal:  Psychopharmacology (Berl)       Date:  2006-09-20       Impact factor: 4.530

3.  Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats.

Authors:  Lisa E Baker; Timothy J Van Tilburg; Andrew E Brandt; Alan Poling
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

4.  Effects of combining ethanol (EtOH) with gamma-hydroxybutyrate (GHB) on the discriminative stimulus, locomotor, and motor-impairing functions of GHB in mice.

Authors:  Charles D Cook; Laura Biddlestone; Andrew Coop; Patrick M Beardsley
Journal:  Psychopharmacology (Berl)       Date:  2006-02-02       Impact factor: 4.530

Review 5.  Principles of laboratory assessment of drug abuse liability and implications for clinical development.

Authors:  Lawrence P Carter; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

6.  Gamma-hydroxybutyric acid in male and female cynomolgus monkeys trained to discriminate 1.0 or 2.0 g/kg ethanol.

Authors:  Christa M Helms; Laura S M Rogers; Kathleen A Grant
Journal:  Behav Pharmacol       Date:  2008-07       Impact factor: 2.293

7.  GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice.

Authors:  Concepción Maldonado; Marta Rodríguez-Arias; María A Aguilar; José Miñarro
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

8.  Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists.

Authors:  Wouter Koek; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2008-04-30       Impact factor: 4.530

9.  Influence of reinforcer type and route of administration on gamma-hydroxybutyrate discrimination in rats.

Authors:  Lisa E Baker; Dori Pynnonen; Alan Poling
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

Review 10.  Behavioral analyses of GHB: receptor mechanisms.

Authors:  Lawrence P Carter; Wouter Koek; Charles P France
Journal:  Pharmacol Ther       Date:  2008-10-29       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.